Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Feys

Showing results (171-180 of 218) with videos related to

Pageof 22
Sort By:
The Journal of International Medical Research|August 14, 2014
Physical therapy in multiple sclerosis differs across Europe: information regarding an ongoing studyKamila Řasová, Patricia Martinkova, Davide Cattaneo, et al.
Annals of Physical and Rehabilitation Medicine|December 10, 2024
Prevalence of distance walking fatigability in multiple sclerosis according to MS phenotype, disability severity and walking speedFelipe Balistieri Santinelli, Zuhal Abasıyanık, Ulrik Dalgas, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 19, 2019
A pilot study of the effects of running training on visuospatial memory in MS: A stronger functional embedding of the hippocampus in the default-mode network?Marijn Huiskamp, Lousin Moumdjian, Paul van Asch, et al.
Journal of Neuroengineering and Rehabilitation|September 25, 2016
Evaluation of upper extremity neurorehabilitation using technology: a European Delphi consensus study within the EU COST Action Network on Robotics for NeurorehabilitationAnn-Marie Hughes, Sofia Barbosa Bouças, Jane H Burridge, et al.
CNS Drugs|December 12, 2018
Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release FampridineJeremy Hobart, Tjalf Ziemssen, Peter Feys, et al.
Therapeutic Advances in Neurological Disorders|October 12, 2018
Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience. Report of an expert meetingPhilipp Albrecht, Ingrid Kristine Bjørnå, David Brassat, et al.
Journal of Neuroengineering and Rehabilitation|November 9, 2021
European evidence-based recommendations for clinical assessment of upper limb in neurorehabilitation (CAULIN): data synthesis from systematic reviews, clinical practice guidelines and expert consensusGerdienke B Prange-Lasonder, Margit Alt Murphy, Ilse Lamers, et al.
Contemporary Clinical Trials Communications|March 6, 2024
Effects of power training in older patients with multiple sclerosis on neurodegeneration, neuromuscular function, and physical function. A study protocol for the "power training in older multiple sclerosis patients (PoTOMS) randomized control trialTobias Gaemelke, Christoffer Laustsen, Peter Feys, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 29, 2011
Which walking capacity tests to use in multiple sclerosis? A multicentre study providing the basis for a core setDomien Gijbels, Ulrik Dalgas, Anders Romberg, et al.
Journal of the Neurological Sciences|January 21, 2014
Within-day variability on short and long walking tests in persons with multiple sclerosisPeter Feys, Bo Bibby, Anders Romberg, et al.
Pageof 22

Showing results (171-180 of 218) with videos related to

Sort By:
Pageof 22
The Journal of International Medical Research|August 14, 2014
Physical therapy in multiple sclerosis differs across Europe: information regarding an ongoing studyKamila Řasová, Patricia Martinkova, Davide Cattaneo, et al.
Annals of Physical and Rehabilitation Medicine|December 10, 2024
Prevalence of distance walking fatigability in multiple sclerosis according to MS phenotype, disability severity and walking speedFelipe Balistieri Santinelli, Zuhal Abasıyanık, Ulrik Dalgas, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 19, 2019
A pilot study of the effects of running training on visuospatial memory in MS: A stronger functional embedding of the hippocampus in the default-mode network?Marijn Huiskamp, Lousin Moumdjian, Paul van Asch, et al.
Journal of Neuroengineering and Rehabilitation|September 25, 2016
Evaluation of upper extremity neurorehabilitation using technology: a European Delphi consensus study within the EU COST Action Network on Robotics for NeurorehabilitationAnn-Marie Hughes, Sofia Barbosa Bouças, Jane H Burridge, et al.
CNS Drugs|December 12, 2018
Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release FampridineJeremy Hobart, Tjalf Ziemssen, Peter Feys, et al.
Therapeutic Advances in Neurological Disorders|October 12, 2018
Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience. Report of an expert meetingPhilipp Albrecht, Ingrid Kristine Bjørnå, David Brassat, et al.
Journal of Neuroengineering and Rehabilitation|November 9, 2021
European evidence-based recommendations for clinical assessment of upper limb in neurorehabilitation (CAULIN): data synthesis from systematic reviews, clinical practice guidelines and expert consensusGerdienke B Prange-Lasonder, Margit Alt Murphy, Ilse Lamers, et al.
Contemporary Clinical Trials Communications|March 6, 2024
Effects of power training in older patients with multiple sclerosis on neurodegeneration, neuromuscular function, and physical function. A study protocol for the "power training in older multiple sclerosis patients (PoTOMS) randomized control trialTobias Gaemelke, Christoffer Laustsen, Peter Feys, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 29, 2011
Which walking capacity tests to use in multiple sclerosis? A multicentre study providing the basis for a core setDomien Gijbels, Ulrik Dalgas, Anders Romberg, et al.
Journal of the Neurological Sciences|January 21, 2014
Within-day variability on short and long walking tests in persons with multiple sclerosisPeter Feys, Bo Bibby, Anders Romberg, et al.
Pageof 22